01:07:31 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-04-03 Årsstämma 2025
2025-02-26 Bokslutskommuniké 2024
2024-11-07 Kvartalsrapport 2024-Q3
2024-08-28 Kvartalsrapport 2024-Q2
2024-05-03 Kvartalsrapport 2024-Q1
2024-05-01 Ordinarie utdelning NSIS B 2.00 DKK
2024-04-30 Årsstämma 2024
2024-03-04 Extra Bolagsstämma 2024
2024-02-08 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-10-13 Bonusutdelning NSIS B 4.2
2023-08-09 Kvartalsrapport 2023-Q2
2023-04-26 Kvartalsrapport 2023-Q1
2023-03-30 Extra Bolagsstämma 2023
2023-03-03 Ordinarie utdelning NSIS B 6.00 DKK
2023-03-02 Årsstämma 2023
2023-01-26 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-11 Kvartalsrapport 2022-Q2
2022-04-27 Kvartalsrapport 2022-Q1
2022-03-17 Ordinarie utdelning NSIS B 5.50 DKK
2022-03-16 Årsstämma 2022
2022-02-01 Bokslutskommuniké 2021
2021-10-27 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-04-27 Kvartalsrapport 2021-Q1
2021-03-12 Ordinarie utdelning NSIS B 5.25 DKK
2021-03-11 Årsstämma 2021
2021-02-02 Bokslutskommuniké 2020
2020-10-21 Kvartalsrapport 2020-Q3
2020-08-12 Kvartalsrapport 2020-Q2
2020-04-29 Kvartalsrapport 2020-Q1
2020-02-27 Ordinarie utdelning NSIS B 5.25 DKK
2020-02-26 Årsstämma 2020
2020-01-23 Bokslutskommuniké 2019
2019-10-23 Kvartalsrapport 2019-Q3
2019-08-08 Kvartalsrapport 2019-Q2
2019-04-24 Kvartalsrapport 2019-Q1
2019-02-28 Ordinarie utdelning NSIS B 5.00 DKK
2019-02-27 Årsstämma 2019
2019-01-24 Bokslutskommuniké 2018
2018-10-24 Kvartalsrapport 2018-Q3
2018-08-10 Kvartalsrapport 2018-Q2
2018-04-25 Kvartalsrapport 2018-Q1
2018-03-14 Ordinarie utdelning NSIS B 4.50 DKK
2018-03-13 Årsstämma 2018
2018-02-07 Bokslutskommuniké 2017
2017-10-25 Kvartalsrapport 2017-Q3
2017-08-11 Kvartalsrapport 2017-Q2
2017-04-26 Kvartalsrapport 2017-Q1
2017-02-23 Ordinarie utdelning NSIS B 4.00 DKK
2017-02-22 Årsstämma 2017
2017-01-18 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-10 Kvartalsrapport 2016-Q2
2016-04-20 Kvartalsrapport 2016-Q1
2016-02-25 Ordinarie utdelning NSIS B 3.50 DKK
2016-02-24 Årsstämma 2016
2016-01-19 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-08-06 Kvartalsrapport 2015-Q2
2015-04-23 Kvartalsrapport 2015-Q1
2015-02-26 Ordinarie utdelning NSIS B 3.00 DKK
2015-02-25 Årsstämma 2015
2015-01-20 Bokslutskommuniké 2014
2014-10-23 Kvartalsrapport 2014-Q3
2014-08-14 Kvartalsrapport 2014-Q2
2014-04-24 Kvartalsrapport 2014-Q1
2014-02-27 Ordinarie utdelning NSIS B 2.50 DKK
2014-02-26 Årsstämma 2014
2014-01-21 Bokslutskommuniké 2013
2013-10-25 Kvartalsrapport 2013-Q3
2013-08-09 Kvartalsrapport 2013-Q2
2013-04-25 Kvartalsrapport 2013-Q1
2013-03-01 Ordinarie utdelning NSIS B 2.20 DKK
2013-02-28 Årsstämma 2013
2012-10-25 Kvartalsrapport 2012-Q3
2012-08-16 Kvartalsrapport 2012-Q2
2012-04-25 Kvartalsrapport 2012-Q1
2012-03-01 Ordinarie utdelning NSIS B 1.90 DKK
2012-02-29 Årsstämma 2012
2012-01-19 Bokslutskommuniké 2011
2011-11-28 Split NSIS B 1:5
2011-10-28 Kvartalsrapport 2011-Q3
2011-08-11 Kvartalsrapport 2011-Q2
2011-04-29 Kvartalsrapport 2011-Q1
2011-03-03 Ordinarie utdelning NSIS B 8.00 DKK
2011-03-02 Årsstämma 2011
2011-01-21 Bokslutskommuniké 2010
2010-10-28 Kvartalsrapport 2010-Q3
2010-08-12 Kvartalsrapport 2010-Q2
2010-04-29 Kvartalsrapport 2010-Q1
2010-03-04 Ordinarie utdelning NSIS B 5.75 DKK
2010-03-03 Årsstämma 2010
2009-03-05 Ordinarie utdelning NSIS B 5.25 DKK
2008-03-06 Ordinarie utdelning NSIS B 5.00 DKK
2007-03-09 Ordinarie utdelning NSIS B 4.50 DKK
2006-03-02 Ordinarie utdelning NSIS B 4.00 DKK
2005-03-17 Ordinarie utdelning NSIS B 3.50 DKK
2004-03-18 Ordinarie utdelning NSIS B 3.15 DKK
2003-03-20 Ordinarie utdelning NSIS B 2.25 DKK
2002-03-21 Ordinarie utdelning NSIS B 2.00 DKK
2001-03-22 Ordinarie utdelning NSIS B 1.65 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriBioteknik
Novonesis är verksamma inom biokemi. Bolaget utvecklar enzymer och mikroorganismer för industriellt bruk. Enzymerna är ett protein som används inom ett flertal olika branscher, huvudsakligen inom jordbruks- och livsmedelsindustrin. Produkterna används inom livsmedel samt kläder, och försäljning innehas på global nivå, med störst närvaro inom Norden och Europa. Bolaget har sitt huvudkontor i Bagsværd.
2023-11-09 08:51:20

Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an enzymatic solution designed to transform the feedstock pre-treatment process.

Copenhagen, Denmark – 9 November, 2023. As the world seeks sustainable alternatives to traditional fuels, renewable diesel and SAF production have taken center stage. By 2030, vegetable oils are projected to account for over 40% of global feedstock used in renewable diesel and SAF production. However, producers have long grappled with challenges related to feedstock availability, pricing fluctuations, and the ever-increasing market demand.

To address these pressing issues, Novozymes has leveraged its extensive experience in enzymatic degumming, which has resulted in Quara LowP, an innovative solution that gives customers flexibility to process mixed feedstocks without negatively impacting their bottom line.

"This innovation is a testament to our commitment to sustainable solutions for the renewable diesel and SAF industry. Quara LowP offers producers the flexibility to process blends of feedstocks resulting in increased efficiency, reduced operating costs, and lowered environmental impact. It is a great contribution to the industry and a reflection of Novozymes' dedication to rethinking tomorrow" said Hans Ole Klingenberg, VP Marketing, Ag & Industrial biosolutions at Novozymes.

A sustainable solution for a growing demand
Quara LowP facilitates the efficient processing of HVO (Hydrotreated Vegetable Oil) and HEFA (Hydroprocessed Esters and Fatty Acids) feedstocks. By pretreating these feedstocks with Quara LowP, producers can achieve higher yields and significantly lower operational costs, all while reducing the environmental footprint of their operations.

This innovation holds profound significance for the HVO and SAF industry:

  • Increased efficiency: HVO/HEFA feedstock producers now have a means to process blends of vegetable oils with other lipid feedstocks without compromising yield or incurring additional operating costs. The current practice of overusing bleaching earth/bleaching clay to address contaminants in vegetable oils when blending with waste oils is a thing of the past. Quara LowP offers a more efficient and cost-effective solution.
  • Economic benefits: With Quara LowP, producers can enjoy increased yields and lower operating costs, overcoming process inefficiencies.
  • Environmental impact: The industry can benefit from a greener operation, with reduced waste handling hazards and lower water consumption, aligning with the global sustainability goals.

As Novozymes ventures into the renewable diesel/SAF industry, which is projected to grow at a compound annual growth rate (CAGR) of 12% from 2023 to 2027, Quara LowP is set to play a pivotal role in driving the industry's growth, sustainability, and efficiency.

For more information about Quara LowP and Novozymes' biosolutions for renewable diesel feedstocks, please visit https://www.novozymes.com/en/solutions/renewable-diesel.

About Novozymes  
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com  
   
NASDAQ OMX: NZYM-B • 6,500 employees • DKK 15 billion turnover • 30+ industries • 700+ products 
 

Media Relations   
Lina Danstrup 
Head of External Communications 
Phone: +45 30 77 05 52 
lind@novozymes.com  
  
 
   
Investor Relations   
Tobias Cornelius Björklund 
Head of Investor Relations 
Phone: +45 30 77 86 82 
tobb@novozymes.com